• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索靶向泛素-蛋白酶体系统治疗阿尔茨海默病的前景。

Exploring the Promise of Targeting Ubiquitin-Proteasome System to Combat Alzheimer's Disease.

机构信息

Department of Pharmacy, Southeast University, Dhaka, Bangladesh.

Pharmakon Neuroscience Research Network, Dhaka, Bangladesh.

出版信息

Neurotox Res. 2020 Jun;38(1):8-17. doi: 10.1007/s12640-020-00185-1. Epub 2020 Mar 9.

DOI:10.1007/s12640-020-00185-1
PMID:32157628
Abstract

The ubiquitin (Ub)-proteasome system (UPS) is considered as a central protein degradation system in all eukaryotes. The UPS comprises of several factors such as Ub and Ub-like molecules, Ub hydrolases, E3 Ub ligases, and the proteasome itself. Numerous studies have demonstrated that the dysfunction of UPS plays an essential role in the pathogenesis and progression of Alzheimer's disease (AD). Furthermore, current evidence has suggested that the UPS components can be connected with the initial stage of AD that is characterized by synaptic dysfunction, and to the late phases of AD, marked by neurodegeneration. In AD patients, the accumulations of insoluble protein in the brain can be caused by overload or dysfunction of the UPS, or by conformational alterations in the protein substrates that prevent their degradation and recognition by the UPS. Synaptic dysfunction is also caused by defective proteolysis that has found in the initial stage in AD as the UPS is widely recognized to play a pivotal role in the regular activities of synapses. Conversely, its precise cause and pathogenesis are unclear. Presently accepted medicines for AD give symptomatic relief, though they are unable to stop the progression of the disease. Besides, the components of the cellular quality control system demonstrate a significant emphasis on the advancement of targeted and effective treatments for AD. In this review, we focus on the role of UPS in the pathogenesis of AD and highlight how the UPS-linked treatments influence in the management of AD.

摘要

泛素(Ub)-蛋白酶体系统(UPS)被认为是所有真核生物中中央蛋白质降解系统。UPS 由 Ub 和 Ub 样分子、Ub 水解酶、E3 Ub 连接酶和蛋白酶体本身等几个因素组成。大量研究表明,UPS 的功能障碍在阿尔茨海默病(AD)的发病机制和进展中起着至关重要的作用。此外,目前的证据表明,UPS 成分可以与 AD 的早期阶段有关,该阶段以突触功能障碍为特征,并与 AD 的晚期阶段有关,其特征是神经退行性变。在 AD 患者中,大脑中不溶性蛋白质的积累可能是由于 UPS 的过载或功能障碍,或由于蛋白质底物的构象改变,从而阻止它们被 UPS 降解和识别。突触功能障碍也是由缺陷性蛋白水解引起的,在 AD 的早期阶段就已经发现 UPS 广泛被认为在突触的正常活动中起着关键作用。相反,其确切的原因和发病机制尚不清楚。目前用于 AD 的药物只能缓解症状,而不能阻止疾病的进展。此外,细胞质量控制系统的组成部分对 AD 的靶向和有效治疗的进展表现出显著的重视。在这篇综述中,我们重点介绍 UPS 在 AD 发病机制中的作用,并强调 UPS 相关治疗如何影响 AD 的治疗管理。

相似文献

1
Exploring the Promise of Targeting Ubiquitin-Proteasome System to Combat Alzheimer's Disease.探索靶向泛素-蛋白酶体系统治疗阿尔茨海默病的前景。
Neurotox Res. 2020 Jun;38(1):8-17. doi: 10.1007/s12640-020-00185-1. Epub 2020 Mar 9.
2
Molecular Insight into the Crosstalk of UPS Components and Alzheimer's Disease.分子洞察 UPS 组件与阿尔茨海默病的串扰。
Curr Protein Pept Sci. 2020;21(12):1193-1201. doi: 10.2174/1389203721666200923153406.
3
Role of the ubiquitin proteasome system in Alzheimer's disease.泛素蛋白酶体系统在阿尔茨海默病中的作用。
BMC Biochem. 2007 Nov 22;8 Suppl 1(Suppl 1):S12. doi: 10.1186/1471-2091-8-S1-S12.
4
Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer's disease.阿尔茨海默病中β-淀粉样蛋白与泛素-蛋白酶体系统的关系。
Neurol Res. 2014 Mar;36(3):276-82. doi: 10.1179/1743132813Y.0000000288.
5
The role of ubiquitin-proteasome in the metabolism of amyloid precursor protein (APP): implications for novel therapeutic strategies for Alzheimer's disease.泛素-蛋白酶体在淀粉样前体蛋白(APP)代谢中的作用:对阿尔茨海默病新型治疗策略的启示
Discov Med. 2014 Jul-Aug;18(97):41-50.
6
Protein quality control in Alzheimer's disease by the ubiquitin proteasome system.泛素蛋白酶体系统在阿尔茨海默病中的蛋白质质量控制
Prog Neurobiol. 2004 Dec;74(5):249-70. doi: 10.1016/j.pneurobio.2004.10.001.
7
Dysfunction of different cellular degradation pathways contributes to specific β-amyloid42-induced pathologies.不同细胞降解途径的功能障碍导致了特定的β-淀粉样蛋白 42 诱导的病理学。
FASEB J. 2018 Mar;32(3):1375-1387. doi: 10.1096/fj.201700199RR. Epub 2018 Jan 3.
8
The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease.泛素蛋白酶体系统:阿尔茨海默病治疗的潜在靶点。
J Cell Mol Med. 2016 Jul;20(7):1392-407. doi: 10.1111/jcmm.12817. Epub 2016 Mar 29.
9
Exploration of Aberrant E3 Ligases Implicated in Alzheimer's Disease and Development of Chemical Tools to Modulate Their Function.与阿尔茨海默病相关的异常E3连接酶的探索及调节其功能的化学工具的开发。
Front Cell Neurosci. 2021 Nov 18;15:768655. doi: 10.3389/fncel.2021.768655. eCollection 2021.
10
The Ubiquitin System in Alzheimer's Disease.阿尔茨海默病中的泛素系统。
Adv Exp Med Biol. 2020;1233:195-221. doi: 10.1007/978-3-030-38266-7_8.

引用本文的文献

1
Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?增强大脑清理能力:靶向泛素蛋白酶体系统基因能否提供神经保护?
Mol Neurobiol. 2025 Aug 16. doi: 10.1007/s12035-025-05263-z.
2
Research progress on resistance exercise therapy for improving cognitive function in patients with AD and muscle atrophy.抗阻运动疗法改善阿尔茨海默病患者认知功能及肌肉萎缩的研究进展
Front Aging Neurosci. 2025 Apr 8;17:1552905. doi: 10.3389/fnagi.2025.1552905. eCollection 2025.
3
The Role and Mechanisms of Ubiquitin-Proteasome System-Mediated Ferroptosis in Neurological Disorders.
泛素-蛋白酶体系统介导的铁死亡在神经系统疾病中的作用及机制
Neurosci Bull. 2025 Apr;41(4):691-706. doi: 10.1007/s12264-024-01343-7. Epub 2025 Jan 7.
4
Recent advances in potential enzymes and their therapeutic inhibitors for the treatment of Alzheimer's disease.用于治疗阿尔茨海默病的潜在酶及其治疗性抑制剂的最新进展。
Heliyon. 2024 Nov 28;10(23):e40756. doi: 10.1016/j.heliyon.2024.e40756. eCollection 2024 Dec 15.
5
Neddylation of protein, a new strategy of protein post-translational modification for targeted treatment of central nervous system diseases.蛋白质的Neddylation修饰,一种用于中枢神经系统疾病靶向治疗的蛋白质翻译后修饰新策略。
Front Neurosci. 2024 Nov 5;18:1467562. doi: 10.3389/fnins.2024.1467562. eCollection 2024.
6
Pirh2 modulates the mitochondrial function and cytochrome c-mediated neuronal death during Alzheimer's disease.Pirh2 调节阿尔茨海默病中的线粒体功能和细胞色素 c 介导线粒体神经元死亡。
Cell Death Dis. 2024 May 13;15(5):331. doi: 10.1038/s41419-024-06662-1.
7
Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer's disease.蛋白质稳态与神经退行性变:深入探讨阿尔茨海默病中的自噬
Front Aging Neurosci. 2023 Nov 2;15:1281338. doi: 10.3389/fnagi.2023.1281338. eCollection 2023.
8
Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier.通过血脑屏障将蛋白酶靶向嵌合体(PROTAC)递送至大脑
Antibodies (Basel). 2023 Jun 26;12(3):43. doi: 10.3390/antib12030043.
9
The Role of Clusterin Transporter in the Pathogenesis of Alzheimer's Disease at the Blood-Brain Barrier Interface: A Systematic Review.簇集蛋白转运体在血脑屏障界面阿尔茨海默病发病机制中的作用:系统评价。
Biomolecules. 2022 Oct 10;12(10):1452. doi: 10.3390/biom12101452.
10
Pathophysiological Mechanisms Explaining the Association Between Low Skeletal Muscle Mass and Cognitive Function.解释低骨骼肌量与认知功能之间关联的病理生理机制。
J Gerontol A Biol Sci Med Sci. 2022 Oct 6;77(10):1959-1968. doi: 10.1093/gerona/glac121.